期刊文献+

早期生长反应蛋白1参与肝病发生主要病理机制研究进展 被引量:4

Research progress in involvement of early growth response factor protein 1 in pathogenesis of chronic liver diseases
在线阅读 下载PDF
导出
摘要 早期生长反应蛋白1(EGR1)属于即刻早期基因家族,是重要核转录因子,参与调控多种蛋白。EGR1在各种刺激下可快速诱导表达,参与丝裂原活化蛋白激酶等通路的下游信号转导,与细胞增殖分化与凋亡、组织损伤、再生修复等的调控机制密切相关。EGR1参与肝再生、细胞生长分化和细胞凋亡等生物学功能,并参与肝纤维化、胆汁淤积性肝病、酒精性脂肪肝和肝癌等病理生理机制。EGR1可能改善肝病的病理病变,也可能加速病情发展,其机制可能涉及EGR1的负反馈调节及其下游靶基因发挥的功能等。关注EGR1在临床研究的调控机制,旨在为探寻肝病的治疗靶点提供新线索。 Early growth response factor protein 1(EGR1),a member of the immediate early gene family,is an important nuclear transcription factor involved in the regulation of various proteins.EGR1 can be rapidly induced and expressed when stimulated by various factors participate in the downstream signal transduction of signaling pathways,such as mitogen-activated protein kinase pathways,which is closely related to cell proliferation,differentiation,apoptosis,tissue damage,and regeneration repair.The biological functions of EGR1 are manifested by its involvement in liver regeneration,cell growth and differentiation,and cell apoptosis,and its pathophysiological mechanisms are possibley related to liver fibrosis,cholestatic liver disease,alcoholic fatty liver and hepatocellular carcinoma.EGR1 can improve the pathological changes in liver disease.Meanwhile,it can also accelerate the progression of liver disease.The negative feedback regulation mechanism of EGR1 and the diverse functions of its downstream target genes may play a role in these pathways.This paper focuses on the regulatory mechanism of EGR1 in clinical research,and is expected to offer some novel clues to the investigation of the therapeutic targets in liver diseases.
作者 曾伟兰 汪艳 ZENG Wei-lan;WANG Yan(School of Pharmaceutical Science,Southern Medical University,Guangzhou 510515,China;Biomedical Research Center,Southern Medical University,Guangzhou 510515,China;Guangdong Provincial Research Institute of Liver Fibrosis,Guangzhou 510515,China)
出处 《中国药理学与毒理学杂志》 CAS 北大核心 2020年第9期702-712,共11页 Chinese Journal of Pharmacology and Toxicology
基金 国家自然科学基金(81670522) 国家自然科学基金(82070589) 深圳市“三名工程项目”(SZSM201911001) 南方医科大学南方医院院长基金(2018Z016)。
关键词 早期生长反应蛋白1 肝再生 肝损伤 early growth response factor protein 1 liver regeneration liver damage
  • 相关文献

参考文献2

二级参考文献41

  • 1Yu Cheng Tang,Yu Li,Guan Xiang Qian Department of Biochemistry, Shanghai Second Medical University, Shanghai 200025, China.Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy[J].World Journal of Gastroenterology,2001,7(1):22-27. 被引量:33
  • 2LIU Cheng Gang 1, ZHU Mei Cai 1 and CHEN Zhi Nan 2.Preparation and purification of F(ab′) _2 fragment from anti hepatoma mouse IgG_1 mAb[J].World Journal of Gastroenterology,1999,5(6):522-524. 被引量:1
  • 3[1]Zhou Z,Wang L,Song Z,Lambert JC,McClain CJ,Kang YJ.A critical involvement of oxidative stress in acute alcoholinduced hepatic TNF-alpha production.Am J Pathol 2003; 163:1137-1146
  • 4[2]Naveau S,Giraud V,Borotto E,Aubert A,Capron F,Chaput JC.Excess weight risk factor for alcoholic liver disease.Hepatology 1997; 25:108-111
  • 5[3]Feher J,Lengyel G.A new approach to drug therapy in nonalcoholic steatohepatitis (NASH).J Int Med Res 2003; 31:537-551
  • 6[4]Lieber CS.New pathway of ethanol metabolism in the liver.Gastroenterology 1970; 59:930-937
  • 7[5]Lieber CS.Hepatic,metabolic and toxic effects of ethanol:1991 update.Alcohol Clin Exp Res 1991; 15:573-592
  • 8[6]Lieber CS,DeCarli LM.Hepatotoxicity of ethanol.J Hepatol 1991; 12:394-401
  • 9[7]Lieber CS,Savolainen M.Ethanol and lipids.Alcohol Clin Exp Res 1984; 8:409-423
  • 10[8]Carrasco MP,Jimenez-Lopez JM,Segovia JL,Marco C.Comparative study of the effects of short-and long-term ethanol treatment and alcohol withdrawal on phospholipid biosynthesis in rat hepatocytes.Comp Biochem Physiol B Biochem Mol Biol 2002; 131:491-497

共引文献44

同被引文献57

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部